Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

Por Jørgensen, Nicolai Grønne, Ahmad, Shamaila Munir, Abildgaard, Niels, Straten, Per Thor, Svane, Inge Marie, Andersen, Mads Hald, Knudsen, Lene Meldgaard
Publicado no Stem Cell Investig (2016)

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

Por Hjorth, Martin, Hjertner, Øyvind, Knudsen, Lene Meldgaard, Gulbrandsen, Nina, Holmberg, Erik, Pedersen, Per Trøllund, Andersen, Niels Frost, Andréasson, Björn, Billström, Rolf, Carlson, Kristina, Carlsson, Margaretha S, Flogegård, Max, Forsberg, Karin, Gimsing, Peter, Karlsson, Torbjörn, Linder, Olle, Nahi, Hareth, Othzén, Annika, Swedin, Agneta
Publicado em 2012

FDG PET/CT in cancer: comparison of actual use with literature-based recommendations

Por Petersen, Henrik, Holdgaard, Paw Christian, Madsen, Poul Henning, Knudsen, Lene Meldgaard, Gad, Dorte, Gravergaard, Anders Eggert, Rohde, Max, Godballe, Christian, Engelmann, Bodil Elisabeth, Bech, Karsten, Teilmann-Jørgensen, Dorte, Mogensen, Ole, Karstoft, Jens, Johansen, Jørgen, Christensen, Janne Buck, Johansen, Allan, Høilund-Carlsen, Poul Flemming
Publicado no Eur J Nucl Med Mol Imaging (2015)

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

Por Jørgensen, Nicolai Grønne, Klausen, Uffe, Grauslund, Jacob Handlos, Helleberg, Carsten, Aagaard, Thomas Granum, Do, Trung Hieu, Ahmad, Shamaila Munir, Olsen, Lars Rønn, Klausen, Tobias Wirenfeldt, Breinholt, Marie Fredslund, Hansen, Morten, Martinenaite, Evelina, Met, Özcan, Svane, Inge Marie, Knudsen, Lene Meldgaard, Andersen, Mads Hald
Publicado no Front Immunol (2020)